Key result
The eNOS D298 and IVS18 + 27C alleles were significantly more frequent in 159 type 2 diabetic patients compared to 207 healthy controls, suggesting a genetic susceptibility to insulin resistance.
Why the study?
Are eNOS gene polymorphisms associated with type 2 diabetes and insulin resistance syndrome?
Case-Control (n=366)
Are eNOS gene polymorphisms associated with type 2 diabetes and insulin resistance syndrome?
eNOS gene polymorphisms (D298 and IVS18 + 27C) are significantly associated with type 2 diabetes and insulin resistance, suggesting a genetic susceptibility factor linking endothelial dysfunction and metabolic disease.
Answers are grounded in this paper and cite their sources.
Should not yet alter diabetes risk assessment or management; leaves open causal role and need for prospective validation in larger cohorts.
Endothelial nitric oxide synthase (eNOS) variants were previously demonstrated in cardiovascular disease. To evaluate whether eNOS gene variants are associated with insulin resistance and type 2 diabetes, we evaluated polymorphisms in Exon7 (E298D), intron 18 (IVS18 + 27A-->C), and intron 23 (IVS23 + 10G-->T) in 159 type 2 diabetic patients without macrovascular complications and in 207 healthy control subjects. Samples for all hormonal and metabolic variables were obtained after an overnight fast. The D298 and IVS18 + 27C alleles, but not the IVS23 + 10G-->T variant, were significantly more frequent in type 2 diabetic patients than in control subjects. The two- and three-loci haplotype analysis showed that there is a statistically significant association between the eNOS variants and type 2 diabetes. No significant differences were observed in the clinical characteristics of type 2 diabetic patients according to genotypes (except for visceral obesity [waist-to-hip ratio], which was significantly more present in D298 homozygotes). Healthy control subjects homozygous for both D298 and IVS18 + 27C presented higher insulin, C-peptide, and nitric oxide levels, as well as higher HOMA (homeostasis model assessment) values than the double wild-type homozygotes, with values superimposable on those found in type 2 diabetic patients. In conclusion, we described a significant association between eNOS gene polymorphisms and type 2 diabetes, suggesting a new genetic susceptibility factor for hyperinsulinemia, insulin resistance, and type 2 diabetes.
No takes yet. Share an insight, caveat, or question.
Monti et al. (2003) conducted a case-control in Type 2 diabetes and insulin resistance syndrome (n=366). eNOS gene polymorphisms (E298D, IVS18 + 27A-->C, IVS23 + 10G-->T) vs. Healthy control subjects / Wild-type genotypes was evaluated on Association of eNOS gene variants with type 2 diabetes. The eNOS D298 and IVS18 + 27C alleles were significantly more frequent in 159 type 2 diabetic patients compared to 207 healthy controls, suggesting a genetic susceptibility to insulin resistance.
Synapse has enriched 10 related papers. Consider them for comparative context: